Loading…

Certara, Inc.CERTCompetitor analysis, valuation and peers

United States · USD·Information Technology›Packaged Software

Drug-development software and consulting using biosimulation to design and speed up pharma clinical trials.

Momentum leader 98
Mkt cap
$1.71B
US dollars, full cap
Free float
64%
of shares outstanding
$/day
$31.8M
20-day average traded
Fwd P/E
27.9×
forward earnings
ROIC−WACC
-9.4 pp
WACC 10.7%
Hurdle
+29 pp
Req g minus delivered
Next earnings
106 days
4 Mar 2027
Close · USD$11.18
1D+1.1%
1W-4.7%
1M+14.3%
3M+28.1%
6M+139.4%
YTD+26.9%
1Y+36.8%
ATR %5.1%
Beta0.52
52w lowhigh11.3% off high

What Certara does

Drug-development software and consulting using biosimulation to design and speed up pharma clinical trials.

Sells annual software licences for its modelling tools and fee-for-service projects in which its scientists run the models and write regulatory submissions for drug developers; services are the larger of its two segments. Project starts depend partly on how well funded drug developers are.

Products and services

  • Simcyp PBPK simulator
  • Phoenix PK/PD software
  • Regulatory/consulting services
  • D360 data science platform

Customers

  • Large pharma R&D
  • Biotech sponsors
  • Regulatory agencies

Where it sits in the supply chain

  • Pharma R&D services
  • Biosimulation software (PBPK/PK-PD)
  • Regulatory science consulting

What could go right

  • More FDA model-informed submissions
  • Biosimulation adoption in biologics

What could go wrong

  • Pharma R&D budget cuts
  • Biotech funding cycles

Moat: narrow (installed base, switching costs, regulatory licence). Simcyp is embedded in regulatory submissions; switching simulation platforms mid-program is costly.

Headquarters: Princeton, New Jersey, US · Founded: 2008 · Employees: 1,576

Named competitors

Certara at a glance

Size Certara (CERT) is a United States Information Technology company (Packaged Software) with a market value of $1.71B, the 1875th largest of 3,085 United States companies the cockpit tracks. Shares closed at $11.18 on 18 Nov 2026.

Performance Over six months the shares gained 139.4%, against -14.5% for the median peer and -2.2% for the United States market (cap-weighted) — highest of 21 in its peer set.

Growth Revenue fell 4.0% over the last twelve months (peer median +11.8%); the operating margin is 4.4% (peer median 4.6%).

Valuation It trades at 27.9× forward earnings against a peer median of 26.9× (10th most expensive of 20).

Price implies For today's price to make sense, revenue must grow about 40% a year for seven years (Req g). Recent delivered growth is +11%, so the hurdle is +29 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 9.4 points below its cost of capital (10.7% WACC).

Backlog Backlog (remaining performance obligations) was $128M at 30 Sep 2026, down 13% on a year earlier — 0.3 years of trailing revenue. Backlog detail →

Short interest Short interest is 16.7% of the free float (30 Oct 2026).

Next results Next results expected around 4 Mar 2027 (exchange calendar; dates can move).

Relative performance

10015020021 May 202621 Aug 202618 Nov 2026CERT 216Peer median 84
Six months, rebased to 100: Certara against the median of its 20 peers (local-currency closes).

Certara financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$399M$419M$385M$354M$336M
Revenue growth—+9%+9%+6%—
Gross profit$199M$201M$177M$168M$160M
EBITDA$88.5M$101M$86.8M$70.1M$88.4M
Net income-$7.60M-$1.59M-$12.1M-$55.4M$14.7M
Free cash flow$78.2M$94.6M$78.8M$81.0M$91.1M
Capital expenditure$29.7M$26.6M$21.0M$15.3M$12.5M
Total debt$301M$305M$312M$298M$308M

Quarterly statements and history in the cockpit →

Certara competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%+100%-20%0%NAZARAKFINTECH002373002354WLTH600633ADEAETOR300166DFINHACK3013166039272121688088FIVN603533CERT6-month return →1-month return →
Up and to the right = strong over both horizons. Certara is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%0×50×100×150×NAZARAKFINTECH002373002354WLTH600633ADEAETOR300166600271DFINHACK3013166039272121688088FIVN603533AIYCERTRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Certara is the large dot.

Capital: growth delivered against growth the price implies

0%+25%+50%+75%0%50%002373002354600633ADEA300459DFINHACK3013162121688088FIVN603533AIYCERTGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Certara is the large dot.

Certara competitors and peer comparison

Head to head with its named competitors (CERT vs SLP vs ICLR vs IQV)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Certara CERT$1.71B+139%-4%4%27.9×40.1%
Simulations Plus SLPn/a+48%n/an/an/an/a
ICON ICLR$14.6B+70%+1%10%17.3×15.9%
Iqvia IQV$42.5B+50%+9%14%18.7×16.8%
Veeva Systems VEEV$44.9B+68%+16%30%28.7×23.1%

How Certara compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Certara against its 20 peers (data as of 18 Nov 2026)
MeasureCERTPeer medianRank in peer set
1-month return+14.3%-3.7%2nd highest of 21
6-month return+139.4%-14.5%highest of 21
Distance from 52-week high-11.3%-40.7%4th highest of 21
Revenue growth (TTM)-4.0%+11.8%4th lowest of 21
Operating margin4.4%4.6%11th highest of 21
Forward P/E27.9×26.9×10th most expensive of 20
Growth the price implies (Req g, 7 yrs)40.1%14.8%3rd most demanding of 16
Growth delivered (Del g)+11.5%+6.8%6th highest of 15
Hurdle (Req g minus delivered)+28.7 pp+15.3 pp3rd most demanding of 15
ROIC minus cost of capital-9.4 pp-5.2 pp7th lowest of 18
EV / EBITDA20.2×7.1×2nd most expensive of 9
Net debt / EBITDA1.0×-0.9×2nd most indebted of 9

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Certara CERTUnited States$1.71B+139%-4%4%27.9×40.1%+11.5%
Nazara Technologies NAZARA.NSIndia$1.71B+41%-2%3%139.2×n/an/a
Kfin Technologies KFINTECH.NSIndia$1.73B+13%+27%32%41.4×n/an/a
China TransInfo Technology 002373.SZChina$1.73B-14%+16%1%36.2×20.0%-2.7%
Tianyu Digital Technology 002354.SZChina$1.67B+11%+8%-2%113.0×22.2%+15.8%
Wealthfront WLTHUnited States$1.67B-8%+18%-41%26.9×-3.7%n/a
Zhejiang Digital Culture Technology 600633.SSChina$1.75B-25%+14%10%17.6×12.3%-2.8%
Adeia ADEAUnited States$1.65B-43%+22%44%11.3×2.5%-13.0%
eToro ETORUnited States$1.65B-49%+1%28%9.8×n/an/a
Business-Intelligence of Oriental Nations 300166.SZChina$1.76B-41%+7%-5%88.1×n/an/a
Aisino 600271.SSChina$1.77B-20%-12%-24%23.6×n/an/a
Zhejiang Jinke Tom Culture Industry 300459.SZChina$1.78B-15%-10%-108%n/a40.7%-12.5%
Donnelley Financial Solutions DFINUnited States$1.62B+70%+5%20%12.2×-4.5%-3.0%
Hacksaw HACK.STSweden$1.62B-35%+21%82%8.0×-10.3%+85.9%
Hydsoft Technology 301316.SZChina$1.81B-46%+19%3%153.8×45.5%+26.7%
Sinosoft 603927.SSChina$1.61B-20%-24%2%40.3×20.6%+0.9%
MIXI 2121.TJapan$1.60B+51%+30%14%9.9×-18.0%+7.5%
ArcSoft 688088.SSChina$1.60B-35%+10%12%44.5×37.5%+6.2%
Five9 FIVNUnited States$1.84B+9%+10%6%6.8×14.8%+21.4%
iReader Technology 603533.SSChina$1.58B+1%+14%-2%72.8×31.8%+9.5%
iFAST AIY.SISingapore$1.85B-10%+35%24%18.3×-11.9%+24.8%

Certara backlog

Certara reported $128M of remaining performance obligations at 30 Sep 2026, down 13% from a year earlier and down 15% from the previous quarter. That is 0.3 years of trailing revenue already under contract. Book-to-bill last quarter: 0.76.

Questions

Who are Certara's main competitors?
Named competitors: Simulations Plus (SLP), ICON plc (ICLR), IQVIA (IQV), Veeva Systems (VEEV). The cockpit's measured peer set (industry) also includes Nazara Technologies (NAZARA.NS), Kfin Technologies (KFINTECH.NS), China TransInfo Technology (002373.SZ), Tianyu Digital Technology (002354.SZ), Wealthfront (WLTH), Zhejiang Digital Culture Technology (600633.SS).
Is Certara expensive compared with its peers?
On forward p/e it trades at 27.9× against a peer median of 26.9×, 10th most expensive of 20 in its peer set. For today's price to make sense, revenue must grow about 40% a year for seven years (Req g). Recent delivered growth is +11%, so the hurdle is +29 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Certara stock performed?
Over six months to 18 Nov 2026 the shares returned +139.4% against -14.5% for the median peer; over one year +36.8%.
What is Certara's backlog?
Certara's remaining performance obligations (contracted revenue not yet recognised) were $128M at 30 Sep 2026, -13% on a year earlier.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.